The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies

por Zhang, Pan, Lehmann, Brian D., Shyr, Yu, Guo, Yan
Publicado 2017

Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy

por Zhang, Wei, Li, Emma, Wang, Lily, Lehmann, Brian D., Chen, X. Steven
Publicado 2023

Patient-derived breast tumor xenografts facilitating personalized cancer therapy

por Landis, Melissa D, Lehmann, Brian D, Pietenpol, Jennifer A, Chang, Jenny C
Publicado 2013

The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer

por Guo, Yan, Yu, Hui, Wang, Jing, Sheng, Quanhu, Zhao, Shilin, Zhao, Ying-Yong, Lehmann, Brian D.
Publicado 2018

Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells

por Taylor, Jackson R., Lehmann, Brian D., Chappell, William H., Abrams, Stephen L., Steelman, Linda S., McCubrey, McCubrey
Publicado 2011

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

por Chen, Xi, Li, Jiang, Gray, William H., Lehmann, Brian D., Bauer, Joshua A., Shyr, Yu, Pietenpol, Jennifer A.
Publicado 2012

Detection of internal exon deletion with exon Del

por Guo, Yan, Zhao, Shilin, Lehmann, Brian D, Sheng, Quanhu, Shaver, Timothy M, Stricker, Thomas P, Pietenpol, Jennifer A, Shyr, Yu
Publicado 2014

RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells

por Bauer, Joshua A, Ye, Fei, Marshall, Clayton B, Lehmann, Brian D, Pendleton, Christopher S, Shyr, Yu, Arteaga, Carlos L, Pietenpol, Jennifer A
Publicado 2010

A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

por Mohni, Kareem N., Thompson, Petria S., Luzwick, Jessica W., Glick, Gloria G., Pendleton, Christopher S., Lehmann, Brian D., Pietenpol, Jennifer A., Cortez, David
Publicado 2015

LR Hunting: A Random Forest Based Cell–Cell Interaction Discovery Method for Single-Cell Gene Expression Data

por Lu, Min, Sha, Yifan, Silva, Tiago C., Colaprico, Antonio, Sun, Xiaodian, Ban, Yuguang, Wang, Lily, Lehmann, Brian D., Chen, X. Steven
Publicado 2021

Tissue-specific expression of p73 and p63 isoforms in human tissues

por Marshall, Clayton B., Beeler, J. Scott, Lehmann, Brian D., Gonzalez-Ericsson, Paula, Sanchez, Violeta, Sanders, Melinda E., Boyd, Kelli L., Pietenpol, Jennifer A.
Publicado 2021

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

por Lehmann, Brian D., Jovanović, Bojana, Chen, Xi, Estrada, Monica V., Johnson, Kimberly N., Shyr, Yu, Moses, Harold L., Sanders, Melinda E., Pietenpol, Jennifer A.
Publicado 2016

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

por Ring, Brian Z., Hout, David R., Morris, Stephan W., Lawrence, Kasey, Schweitzer, Brock L., Bailey, Daniel B., Lehmann, Brian D., Pietenpol, Jennifer A., Seitz, Robert S.
Publicado 2016

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

por Ring, Brian Z., Hout, David R., Morris, Stephan W., Lawrence, Kasey, Schweitzer, Brock L., Bailey, Daniel B., Lehmann, Brian D., Pietenpol, Jennifer A., Seitz, Robert S.
Publicado 2016

Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility

por Whalen, Diva S., Widatalla, Sarrah E., Korolkova, Olga Y., Nangami, Gladys S., Beasley, Heather K., Williams, Stephen D., Virgous, Carlos, Lehmann, Brian D., Ochieng, Josiah, Sakwe, Amos M.
Publicado 2019

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer

por Jovanović, Bojana, Beeler, J Scott, Pickup, Michael W, Chytil, Anna, Gorska, Agnieszka E, Ashby, William J, Lehmann, Brian D, Zijlstra, Andries, Pietenpol, Jennifer A, Moses, Harold L
Publicado 2014

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

por Jovanović, Bojana, Sheng, Quanhu, Seitz, Robert S., Lawrence, Kasey D., Morris, Stephan W., Thomas, Lance R., Hout, David R., Schweitzer, Brock L., Guo, Yan, Pietenpol, Jennifer A., Lehmann, Brian D.
Publicado 2017

Annexin A1 Is Required for Efficient Tumor Initiation and Cancer Stem Cell Maintenance in a Model of Human Breast Cancer

por Johnstone, Cameron N., Tu, Yan, Langenbach, Shenna, Baloyan, David, Pattison, Andrew D., Lock, Peter, Britt, Kara L., Lehmann, Brian D., Beilharz, Traude H., Ernst, Matthias, Anderson, Robin L., Stewart, Alastair G.
Publicado 2021

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes

por Redman-Rivera, Lindsay N., Shaver, Timothy M., Jin, Hailing, Marshall, Clayton B., Schafer, Johanna M., Sheng, Quanhu, Hongo, Rachel A., Beckermann, Kathryn E., Wheeler, Ferrin C., Lehmann, Brian D., Pietenpol, Jennifer A.
Publicado 2021

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

por Lehmann, Brian D, Bauer, Joshua A, Schafer, Johanna M, Pendleton, Christopher S, Tang, Luojia, Johnson, Kimberly C, Chen, Xi, Balko, Justin M, Gómez, Henry, Arteaga, Carlos L, Mills, Gordon B, Sanders, Melinda E, Pietenpol, Jennifer A
Publicado 2014